GlassScriptPhysician profile
Gretchen Carlin
NPI 1629592209
$1,370.30
in general payments reported to CMS, 2019-2025
14 companies · $306 in 2025
The $306 reported for 2025 was more than what 85% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $176 · 2022: $214 · 2023: $284 · 2024: $391 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $357.89 | 2022-2025 | Doc Band |
| Tris Pharma INC | $211.44 | 2021-2025 | Dyanavel Xr, Quillichew Er, Onyda Xr |
| Merck Sharp & Dohme LLC | $184.45 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Kaleo, INC. | $134.37 | 2021-2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $116.28 | 2021-2025 | Bexsero, Pediarix, Rotarix |
| Takeda Pharmaceuticals U.S.A., INC. | $78.41 | 2021-2022 | |
| Pfizer INC. | $73.16 | 2024-2025 | |
| Verrica Pharmaceuticals INC. | $65.33 | 2023-2024 | Ycanth |
| Supernus Pharmaceuticals, INC. | $38.02 | 2025 | Qelbree |
| Kowa Pharmaceuticals America, INC. | $35.85 | 2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $22.82 | 2025 | |
| Corium, LLC | $19.50 | 2023 | Azstarys |
| Sobi, INC | $19.10 | 2023 | |
| Adlon Therapeutics L.P. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Carlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.